Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

71 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
MHC class II signaling in antigen-presenting cells.
Al-Daccak R, Mooney N, Charron D. Al-Daccak R, et al. Curr Opin Immunol. 2004 Feb;16(1):108-13. doi: 10.1016/j.coi.2003.11.006. Curr Opin Immunol. 2004. PMID: 14734118 Review.
MHC class II isotype-specific signaling complex on human B cells.
Lévéille C, Castaigne JG, Charron D, Al-Daccak R. Lévéille C, et al. Eur J Immunol. 2002 Aug;32(8):2282-91. doi: 10.1002/1521-4141(200208)32:8<2282::AID-IMMU2282>3.0.CO;2-M. Eur J Immunol. 2002. PMID: 12209641
Anti-HLA antibodies in regenerative medicine stem cell therapy.
Charron D, Suberbielle-Boissel C, Tamouza R, Al-Daccak R. Charron D, et al. Hum Immunol. 2012 Dec;73(12):1287-94. doi: 10.1016/j.humimm.2012.06.010. Epub 2012 Jul 10. Hum Immunol. 2012. PMID: 22789622 Review.
MHC class II engagement by its ligand LAG-3 (CD223) contributes to melanoma resistance to apoptosis.
Hemon P, Jean-Louis F, Ramgolam K, Brignone C, Viguier M, Bachelez H, Triebel F, Charron D, Aoudjit F, Al-Daccak R, Michel L. Hemon P, et al. J Immunol. 2011 May 1;186(9):5173-83. doi: 10.4049/jimmunol.1002050. Epub 2011 Mar 25. J Immunol. 2011. PMID: 21441454
The context of HLA-DR/CD18 complex in the plasma membrane governs HLA-DR-derived signals in activated monocytes.
Doisne JM, Castaigne JG, Deruyffelaere C, Dieu-Nosjean MC, Chamot C, Alcaide-Loridan C, Charron D, Al-Daccak R. Doisne JM, et al. Mol Immunol. 2008 Feb;45(3):709-18. doi: 10.1016/j.molimm.2007.07.019. Epub 2007 Aug 24. Mol Immunol. 2008. PMID: 17719638
A CD18-dependent protein kinase C beta-mediated alternative cell death pathway of activated monocytes.
Castaigne JG, Guo W, Lévéille C, Charron D, Al-Daccak R. Castaigne JG, et al. Int Immunol. 2002 Sep;14(9):1003-14. doi: 10.1093/intimm/dxf071. Int Immunol. 2002. PMID: 12202398
Signaling through HLA-DR induces PKC beta-dependent B cell death outside rafts.
Guo W, Castaigne JG, Mooney N, Charron D, Al-Daccak R. Guo W, et al. Eur J Immunol. 2003 Apr;33(4):928-38. doi: 10.1002/eji.200323351. Eur J Immunol. 2003. PMID: 12672059
Soluble MICA-NKG2D interaction upregulates IFN-γ production by activated CD3-CD56+ NK cells: potential impact on chronic graft versus host disease.
Boukouaci W, Al-Daccak R, Dulphy N, Lauden L, Amokrane K, Fortier C, Marzais F, Bennabi M, Peffault de Latour R, Socie G, Toubert A, Charron D, Krishnamoorthy R, Tamouza R. Boukouaci W, et al. Hum Immunol. 2013 Dec;74(12):1536-41. doi: 10.1016/j.humimm.2013.08.281. Epub 2013 Aug 29. Hum Immunol. 2013. PMID: 23994587
Class II transactivator (CIITA) isoform expression and activity in melanoma.
Baton F, Deruyffelaere C, Chapin M, Prod'homme T, Charron D, Al-Daccak R, Alcaide-Loridan C. Baton F, et al. Melanoma Res. 2004 Dec;14(6):453-61. doi: 10.1097/00008390-200412000-00004. Melanoma Res. 2004. PMID: 15577315
Pathologic expression of MHC class II is driven by mitogen-activated protein kinases.
Martins I, Deshayes F, Baton F, Forget A, Ciechomska I, Sylla K, Aoudjit F, Charron D, Al-Daccak R, Alcaide-Loridan C. Martins I, et al. Eur J Immunol. 2007 Mar;37(3):788-97. doi: 10.1002/eji.200636620. Eur J Immunol. 2007. PMID: 17304627
71 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page